# OnCo record familial-pancreatic-cancer (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/familial-pancreatic-cancer/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "familial-pancreatic-cancer" ;
  schema:name "Familial pancreatic cancer and inherited risk (who qualifies for surveillance)"@en ;
  schema:alternateName "Familial pancreatic cancer kindred"@en, "FPC"@en, "Hereditary pancreatic cancer"@en, "Inherited pancreatic cancer risk"@en, "Pancreatic cancer in the family"@en, "Two first-degree relatives with pancreatic cancer"@en, "High-risk individual for pancreatic cancer"@en, "High-risk individual"@en, "HRI"@en, "High-risk individuals in pancreatic surveillance"@en ;
  schema:description "Familial pancreatic cancer means at least two close relatives on the same side of the family have had the disease without a known gene fault to explain it. Members of such families have several times the usual risk, rising steeply with the number of relatives affected. With carriers of certain gene faults, they are the people offered yearly MRI or endoscopic ultrasound in surveillance programmes."@en ;
  schema:url <https://onco.cc/terms/familial-pancreatic-cancer/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Pancreatic_cancer> ;
  schema:citation <https://doi.org/10.1158/0008-5472.can-03-3823>, <https://doi.org/10.1001/jama.2018.6228>, <https://doi.org/10.1200/jco.2017.72.3502>, <https://www.nice.org.uk/guidance/ng85/chapter/Recommendations>, <https://doi.org/10.1136/gutjnl-2019-319352>, <https://doi.org/10.1200/jco.22.00298>, <https://doi.org/10.1136/gutjnl-2020-323611>, <https://doi.org/10.1200/jco.22.00194>, <https://doi.org/10.1038/s41395-018-0395-y>, <https://doi.org/10.1053/j.gastro.2021.08.036>, <https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer/risk-factors>, <https://www.cancerresearchuk.org/about-cancer/pancreatic-cancer/getting-diagnosed/screening> ;
  onco:tag "gi", "pancreatic" ;
  onco:related <https://onco.cc/terms/lynch-syndrome/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/brca-palb2-pdac/>, <https://onco.cc/cancers/ipmn-cystic-precursors/> ;
  onco:technologies <https://onco.cc/technologies/pancreatic-surveillance/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/endoscopic-ultrasound-systems/> ;
  onco:targets <https://onco.cc/targets/brca/>, <https://onco.cc/targets/cdkn2a/>, <https://onco.cc/targets/atm/>, <https://onco.cc/targets/palb2/>, <https://onco.cc/targets/stk11/> ;
  onco:institutions <https://onco.cc/institutions/pancreatic-cancer-uk/> ;
  onco:terms <https://onco.cc/terms/germline-vs-somatic/>, <https://onco.cc/terms/gbrca-mutation/>, <https://onco.cc/terms/pancreatic-cyst-high-risk-stigmata/>, <https://onco.cc/terms/panin/>, <https://onco.cc/terms/stage-shift/> ;
  onco:trials <https://onco.cc/trials/precede/>, <https://onco.cc/trials/europac/> .